Cetera Investment Advisers Ab Cellera Biologics Inc. Transaction History
Cetera Investment Advisers
- $55.9 Billion
- Q2 2025
A detailed history of Cetera Investment Advisers transactions in Ab Cellera Biologics Inc. stock. As of the latest transaction made, Cetera Investment Advisers holds 13,491 shares of ABCL stock, worth $65,701. This represents 0.0% of its overall portfolio holdings.
Number of Shares
13,491
Previous 14,254
5.35%
Holding current value
$65,701
Previous $31,000
48.39%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding ABCL
# of Institutions
154Shares Held
115MCall Options Held
538KPut Options Held
476K-
Baker Bros. Advisors LP New York, NY27.5MShares$134 Million0.96% of portfolio
-
Capital World Investors Los Angeles, CA13.4MShares$65.1 Million0.01% of portfolio
-
Baillie Gifford & CO10.4MShares$50.8 Million0.04% of portfolio
-
Ubs Asset Management Americas Inc Chicago, IL8.47MShares$41.3 Million0.01% of portfolio
-
Credit Suisse Ag Zurich, V84.55MShares$22.1 Million0.02% of portfolio
About AbCellera Biologics Inc.
- Ticker ABCL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 285,139,008
- Market Cap $1.39B
- Description
- AbCellera Biologics Inc. develops antibody discovery platform. Its full-stack, artificial intelligence-powered antibody discovery platform searches and analyzes the database of natural immune systems to find antibodies that could be developed as drugs. As of December 31, 2021, the company had 156 discovery programs that are either completed, in ...